1 / 7

How is Rising Prevalence of Chronic Diseases Driving Biobanking Market?

The rising incidence of chronic diseases and the surging number of research and development (R&D) activities being conducted on genome are the major factors predicted to cause the surge of the global biobanking market, from $25.8 billion to $36.8 billion from 2018 to 2024. In addition to this, the market is predicted to exhibit a CAGR of 6.2% between 2019 and 2024, as per the forecast of P&S Intelligence, a market research company based in India.

Download Presentation

How is Rising Prevalence of Chronic Diseases Driving Biobanking Market?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. In-Depth Analysis of Biobanking Market Current Trends and Future Estimations 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  2. The rising incidence of various chronic conditions and diseases such as Parkinson’s disease, diabetes, and Alzheimer’s disease is pushing up the demand for stem cells and cord blood cells across the globe, on account of the fact that these therapies can help considerably in organ transplantation, tissue grafting, drug testing, and the development of regenerative medicine. This is subsequently pushing up the requirement for biobanks and biobanking solutions across the world. Moreover, due to the surging demand for finding proper and effective treatment procedures for various chronic diseases such as ischemic heart diseases, respiratory disorders, cancer, and diabetes, the governments and national bodies/institutes of many countries are making huge investments in biobanks for preserving, analyzing, transporting, and collecting blood samples. For example, the German Federal Ministry of Education and Research (BMBF) made an allocation of $16 million to 11 German biobanks in May 2017. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/biobanking- market/report-sample Due to the aforementioned factors, the demand for biobanks is growing rapidly across the world. This is driving the advancement of the global biobanking market. As a result, the valuation of the market is predicted to surge from $25.8 billion in 2018 to $36.8 billion by 2024. Furthermore, the market is predicted to progress at a CAGR of 6.2% between 2019 and 2024. Depending on offering, the market is divided into services, software, equipment, and consumables. Out of these, the consumables category is predicted to demonstrate the highest growth in the market in the future years. Furthermore, the software category is predicted to exhibit rapid expansion in the biobanking market in the forthcoming years. When the type of sample is taken into consideration, the market is classified into human tissues, blood products and genetic materials, biological fluids, human waste products, cell lines, and human tissues categories. Out of these, the blood products and genetic material category will register the highest growth in the market in the upcoming years, as per the estimates of P&S Intelligence, a market research company based in India. This is credited to the growing requirement for the preservation of various blood products such as serum, plasma, and platelets all over the world on account of the growing incidence of chronic diseases across the world. Globally, the biobanking market is predicted to demonstrate lucrative growth in the Asia-Pacific (APAC) region in the coming years. This will be a result of the surging clinical research activities and the soaring population of geriatric people in the regional countries. Apart from these factors, the rapid expansion of the 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  3. biotechnology sector, because of the huge investments being made in this sector by both private and public organizations, is also propelling the demand for biobanks in the APAC region. Hence, it can be said with full confidence that the demand for biobanks will surge all over the world in the coming years, primarily because of the rising incidence of chronic diseases, the soaring geriatric population, and the allocation of huge funds for the development of biobanks in healthcare facilities around the world. The research offers market size of the global biobanking market for the period 2014–2024. Market Segmentation by Offering Market Segmentation by Offering Consumables Equipment Services Software Market Segmentation by Sample Type Market Segmentation by Sample Type Blood Products and Genetic Material Human Tissues Cell Lines Biological Fluids Human Waste Products Market Segmentation by Storage Type Market Segmentation by Storage Type Manual Automated Market Segmentation by Application Market Segmentation by Application Clinical Research Life Science and medical Research Regenerative Medicine Market Segmentation by Utility Market Segmentation by Utility Research Routine Epidemiology Market Segmentation by Geography Market Segmentation by Geography North America Biobanking Market • • • • • • • • • • • • • • • • • • oBy offering oBy sample type oBy storage type 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  4. oBy application oBy utility oBy country – U.S. and Canada U.S. biobanking market ▪ By offering By sample type By storage type By application By utility Canada biobanking market By offering By sample type By storage type By application By utility ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Europe Biobanking Market • oBy offering oBy sample type oBy storage type oBy application oBy utility oBy country – Germany, France, U.K., Italy, Spain, and Rest of Europe Germany biobanking market By offering By sample type By storage type By application By utility ▪ ▪ ▪ ▪ ▪ ▪ • o U.K. biobanking market By offering By sample type By storage type By application ▪ ▪ ▪ ▪ ▪ 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  5. By utility ▪ • o France biobanking market By offering By sample type By storage type By application By utility Italy biobanking market By offering By sample type By storage type By application By utility Spain biobanking market By offering By sample type By storage type By application By utility ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ APAC Biobanking Market • oBy offering oBy sample type oBy storage type oBy application oBy utility oBy country – Japan, China, India, and Rest of APAC Japan biobanking market By offering By sample type By storage type By application By utility China biobanking market ▪ ▪ ▪ ▪ ▪ ▪ ▪ 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  6. By offering By sample type By storage type By application By utility India biobanking market By offering By sample type By storage type By application By utility ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Latin America (LATAM) Biobanking Market • oBy offering oBy sample type oBy storage type oBy application oBy utility oBy country – Brazil, Mexico, and Rest of LATAM Middle East and Africa (MEA) Biobanking Market • oBy offering oBy sample type oBy storage type oBy application oBy utility oBy country – Saudi Arabia, South Africa, U.A.E., and Rest of MEA 6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  7. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 7 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

More Related